Exam 2 - Medchem 753, Stevens Inotropics Flashcards

(43 cards)

1
Q

What effects are seen during cardiac failure?

A
Inability of heart to pump blood effectively
- Force of contraction of Cardiac Muscle
 - dec CO; dec BP; Dec Renal Q
Edema in legs/Lungs
Renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the action of all positive Inotropes?

A

They affect the availability of intracellular Ca or inc sensitivity of contractile proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the basic action of cardiac steroids?

A

inhibit the Na/K ATPase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the basic action of Phospodiesterase inhibitors?

A

Block cAMP degradation

  • inc [cAMP]; activating cAMP dependent protein kinases
  • stimulate Ca influx through VG channels,
  • inc release and reaccumulation of CA in SR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the basic action of Ca2+ sensitivity stimulants

A

Inc the effect of existing Ca2+ levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the basic action of B-adrenergic agonists?

A

Leads to inc cAMP production, more forceful contractions due to inc calcium presence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are cardiac steroids different from other average steroids?

A

They are characterized by their 5B, 14B stereochemistry, which results in a curved, or convexely shaped molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 2 different groups of cardiac steroids?

A
  1. Cardenolides

2. Bufadienolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cardenolides

  1. Origin
  2. Chemical structure
A
  1. Plant Origin

2. C-17R group is an alpha-B-unsaturated butyrolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bufadienolides

  1. Origin
  2. Chemical structure
A
  1. Found in Toad Skin

2. C-17R group is a Pyrrone Ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most cardiac sterols naturally occur as ______ and have approximately ______ sugars attached where?

A

Glycosides
1-4 sugars
3B-OH of steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Digitalis Purpurea

A

Flox Glove (purple), it is the commercial source of digitoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Digitalis lanata

A

Woolly foxglove (white) commercial source of digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

in 1785, Digitalis leaves were used to treat several things including swelling. What were some remarkable side effects of the drug?

A

Yellow Vision

Nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What kept most physicians from using digitalis preparations until the 1900s?

A

Narrow therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What site difference between digitoxigenin, Digoxigenin and Gitoxigenin makes the large pharmacological difference in their chemistry?

A

12-OH (Digoxin)
12-H (Digitoxin)
16-OH (gitoxigenin); pharmaceutically irrevelevant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the main cardiac glycoside found in Digitalis Lanata leaves?

A

Lanatoside C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is Digoxin extracted from Digitalis leaves?

A

Lantoside C is treated w/ Bglucosidase, to form acetyldigoxin, which is then treated with NaOH and neutrialized with Ch3COOH to become digoxin

19
Q

Inhibition of Na/K-ATPase has what effect on calcium levels?

A

Increased intracellular Na levels –> increased release of Ca from intracellular stores

20
Q

Why is simultaneous treatment of Lasix and Digoxin dangerous?

A

Lasix lowers extracellular K levels, which increases phosphorylation and eventually the binding affinity of Digoxin

21
Q

What is the result of coadministration of Digoxin and Erythromycin?

A

Erythromycin kills microbes that would otherwise help metabolize orally available digoxin, increasing the amount of Digoxin available.

22
Q

What neuro-hormonal effect does Digoxin have in CHF patients?

A
Inc Parasympathetic (vagal activation)
and decreased sympathetic activity
23
Q

What is the preferred cardiac glycoside for CHF?

24
Q

What is the metabolism for Digoxin?

A

minimal (80% unchanged) Hepatic Metabolism by:

  • Hydrolysis
  • Sulfation
  • Glucuronidation
25
What result would be seen from Quinidine coadminstration with Digoxin?
Increased plasma levels of Digoxin
26
What result would be seen with coadminstration of Verapamil and Digoxin
Increased absorption of Digoxin | Verapamil inhibits intestinal pgp efflux of digoxin
27
What result would be seen with coadministration of Rifampin and Digoxin
Decreased absorption of Digoxin | Rifampin induces intestinal pgp efflux expression
28
What would the results of coadministration of Bile Acid binding resins such as Cholestryamine and Digoxin be?
Decreased Digoxin Absorption
29
What is the plasma protein binding, onset, and 1/2 life for Digoxin?
PPB - 30% Onset - 15-30min T1/2 - 1-2 days
30
What is the plasma protein binding, onset and 1/2 life for digitoxin?
PPB - ~95% onset - 05-2hrs T1/2 - 4-7 days
31
What are the primary problems and side effects of Cardiac Glycosides?
Narrow Therapeutic WIndow | SE: Loss of appetite, blurred vision, GI distress, potentially proarrhythmmic (Afib, Vtach, MI)
32
How would you treat acute toxicity of Digoxin?
Digibind (digoxin immune Fab)
33
What are the disappointing results of most PDE inhibitors?
Inc Mortality rates Inc Incidence of arrhythmias Causes tachycardia Loss of positive inotropic effect w/ chronic use
34
When are PDE3 inhibitors used for CHF?
Acute CHF
35
Why was amrinone renamed in the year 2000?
Was confused with Amiodarone, which led to some fatal medication errors
36
What is the difference in naming between PDE3 inhibitors and PDE5 inhibitors?
PDE3 - ends in 'one' | PDE5 - ends in 'fil'
37
Inamrinone 1. Class, indication 2. Metabolism/T1/2 3. SE 4. Formulations
1. PDE3 inhibitor, Acute CHF 2. 3-4hrs, mainly excreted unchanged in urine 3. Thrombocytopenia (10%) 4. Short term IV
38
Milrinone 1. Class, Indication 2. Metabolism/T1/2 3. SE 4. Formulation
1. PDE3 inhibitor, Acute CHF 2. 30-60min, Mainly excreted unchanged in urine 3. Fewer side effects than Inamrinone 4. Lactate for IV
39
MoA for Ca sensitizing agents
Increase contractility by binding the N-terminus of troponin C and stabilizing the Ca-bound conformation. Activation of ATP-regulated K channels and cause vasodilation in vascular smooth muscle.
40
Levosimendan 1. Class/Indication 2. Formulations
1. Calcium sensitizing agent, CHF | 2. IV formulation for Acute CHF
41
B-adrenergic agent for treatment of CHF
Dobutamine
42
Dobutamine Racemate actions results in what overall effect?
In vasculature, A1 agonist negated by A1-antagonist (no vasodilation) Overall: B1 effect: increased stroke volume and little increase in HR.
43
Dobutamine Administration and Availbility
T1/2 ~2min Only active Rapid first pass COMT (Wrap IV bags in aluminum to prevent oxidation to ortho-quinone)